A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia

NCT00261573 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

593

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Vascular Dementia

Interventions

DRUG: galantamine hydrobromide

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.